Mylan Dismisses “Authorized” Generic Antitrust Claims In W.Va. Lawsuit
This article was originally published in The Pink Sheet Daily
Executive Summary
Company instead is pressing on with antitrust claims filed in a March 2004 lawsuit in San Francisco state court stemming from Procter & Gamble and Watson’s “authorized” generic agreement for Macrobid. The West Virginia litigation would have been duplicative of the California claims, Mylan says.
You may also be interested in...
If You Can’t Beat Them, Join Them: Mylan Reconsiders “Authorized” Generics
Mylan says it is prepared to participate in the "authorized" generics market despite its opposition to such deals
If You Can’t Beat Them, Join Them: Mylan Reconsiders “Authorized” Generics
Mylan says it is prepared to participate in the "authorized" generics market despite its opposition to such deals
CMS Offers “Quickest Fix” To “Authorized” Generics, CEO Coury Says
The Centers for Medicare & Medicaid Services could provide the "quickest fix" for the generic industry's complaints about "authorized" generics, Mylan CEO Robert Coury said Feb. 3